Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/03/2012US20120107306 Antibodies for epidermal growth factor receptor 3 (her3)
05/03/2012US20120107305 Combination Therapy
05/03/2012US20120107304 Combination therapy in treatment of oncological and fibrotic diseases
05/03/2012US20120107303 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
05/03/2012US20120107302 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
05/03/2012US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
05/03/2012US20120107289 Lactic Bacteria and Their Use in the Prevention of Diarrhea
05/03/2012US20120107272 Synthetic methods and derivatives of triphosphate oligonucleotides
05/03/2012US20120107271 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/03/2012US20120107268 Lymph node-targeting nanoparticles
05/03/2012US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120107234 Pan-HER Antibody Composition
05/03/2012US20120107233 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
05/03/2012US20120107231 Metalloproteinase binding proteins
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
05/03/2012US20120104039 Medicament/Dosimeter Combination Packaging
05/03/2012CA2819117A1 Anti-sod1 antibodies and uses thereof
05/03/2012CA2816570A1 Enhanced cancer treatment and monitoring using recombinant vectors
05/03/2012CA2816358A1 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
05/03/2012CA2816291A1 Novel anti-dr5 antibody
05/03/2012CA2816190A1 Methods for capturing virus like particles from plants using expanded bed chromatography
05/03/2012CA2815888A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012CA2815278A1 Immunogenic compositions and methods for treating neurologic disorders
05/03/2012CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012CA2815275A1 Immunogenic composition
05/03/2012CA2815119A1 Means and methods for treating dlbcl
05/03/2012CA2814908A1 Antibodies for the treatment of hiv
05/03/2012CA2813833A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012CA2801890A1 Combinations of anti-s1p antibodies and sphingolipid pathway inhibitors
05/03/2012CA2795577A1 New compositions and methods for treatment of autoimmune and allergic diseases
05/02/2012EP2447719A1 Proteins
05/02/2012EP2447372A2 Anti alpha v beta 6 antibodies and uses thereof
05/02/2012EP2447283A2 Human monoclonal antibodies to activin receptor-like kinase-1 (ALK-1)
05/02/2012EP2447281A1 Novel anti-PLGF antibody
05/02/2012EP2447278A1 Novel immunogenic proteins of Leptospira
05/02/2012EP2447277A1 Vaccine compositions based on modified gp41 immunogens
05/02/2012EP2447275A1 Methods and reagents for treatment of age-related macular degeneration
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446899A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
05/02/2012EP2446897A1 Anti-KIR combination treatments and methods
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2445937A1 Bispecific antibodies that bind to complement proteins
05/02/2012EP2445934A2 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
05/02/2012EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP2445531A2 Methods of increasing neuronal differentiation using antibodies to lysophoshatidic acid
05/02/2012EP2445530A1 Method for treating chronic lymphocytic leukemia
05/02/2012EP2445529A2 Marker differentially expressed in cancer stem cells and methods of using same
05/02/2012EP2445528A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent
05/02/2012EP2445527A2 Vaccine
05/02/2012EP2445526A1 Recombinant rsv antigens
05/02/2012EP2445525A2 Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
05/02/2012EP2445524A1 Cancer vaccine
05/02/2012EP2445523A2 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
05/02/2012EP2445522A1 Immunogenic compositions of staphylococcus aureus antigens
05/02/2012EP2445521A2 Albumin-free botulinum toxin formulations
05/02/2012EP2445520A1 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
05/02/2012EP2445518A1 Cobalamin taxane bioconjugates for treating eye disease
05/02/2012EP2445509A1 Zinc supplementation to increase responsiveness to metalloprotease therapy
05/02/2012EP2445503A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
05/02/2012EP2124993B1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
05/02/2012EP2068918B1 Vaccine composition containing synthetic adjuvant
05/02/2012EP1993603B1 Hepatitis c virus non structural fusion protein
05/02/2012EP1948226B1 A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif
05/02/2012EP1924597B1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants
05/02/2012EP1804835B9 Multimeric constructs
05/02/2012EP1727563B1 Method for amplifying therapeutic vaccine activity
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1597280B1 Monoclonal antibody production by ebv transformation of b cells
05/02/2012EP1528933B1 Pharmaceutical anti-tnf-alpha antibody formulation
05/02/2012EP1372682B1 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012CN1404398B Improved DNA vaccines for production-type animals
05/02/2012CN102439147A Vangl1 peptides and vaccines including the same
05/02/2012CN102439134A Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
05/02/2012CN102439041A Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
05/02/2012CN102438702A Anti-mst1r antibodies and uses thereof
05/02/2012CN102438654A Methods and compositions for treating lupus
05/02/2012CN102438653A Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever
05/02/2012CN102438652A Antibody formulation
05/02/2012CN102438651A Influenza vaccine regimens for pandemic-associated strains
05/02/2012CN102438650A Chlamydia antigens
05/02/2012CN102438649A Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
05/02/2012CN102433353A Eukaryotic expression plasmid of duck AvBD2 gene, and molecular adjuvant and vaccine prepared by using plasmid
05/02/2012CN102433343A Preparation method of trichina and tumor related protein gene and medical application
05/02/2012CN102433309A Complete gene sequence determination for G5-type human rotavirus after MA104 culture
05/02/2012CN102432695A Synthetic method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan and preparation method of Newcastle disease attenuated live vaccine-loaded nanoparticles of N-2-hydroxypropyl trimethyl ammonium chloride chitosan
05/02/2012CN102432673A Brucella bp26 protein epitope, monoclonal antibody and application thereof
05/02/2012CN102430126A Heat-resistant stabilizer for tissue fluid lyophilization, as well as preparation method and application thereof
05/02/2012CN102430120A Adjuvant for enhancing fish vaccine immunization effect and application thereof
05/02/2012CN102430119A Construction method of drug evaluation model for dermal pathology of tuberculosis rabbit
05/02/2012CN102430118A Application of H22 liver cancer cell autophagosome to preparation of liver cancer therapeutic vaccine
05/02/2012CN102121021B cDNA of interferon (IFN)-gamma inducible lysosomal thiol reductase of sheep, cloning method and recombinant application thereof
05/02/2012CN101732703B Composition for antagonizing pyretic effect of endotoxin in vaccine on livestock and application thereof
05/02/2012CN101648013B Preparation method of inactivated vaccine of infectious coryza of chicken
05/02/2012CN101560245B CTL epitope polypeptide of avian influenza H5N1 virus and application thereof
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 1823